A self-reported long-term follow-up of patients operated with either shortening techniques or a TachoSil grafting procedure

Por Horstmann, Marcus, Kwol, Matthias, Amend, Bastian, Hennenlotter, Joerg, Stenzl, Arnulf
Publicado em 2011

Prospective evaluation of fluorescence-guided cystoscopy to detect bladder cancer in a high-risk population: results from the UroScreen-Study

Por Horstmann, Marcus, Banek, Severine, Gakis, Georgios, Todenhöfer, Tilman, Aufderklamm, Stefan, Hennenlotter, Joerg, Stenzl, Arnulf, Schwentner, Christian
Publicado em 2014

Assessment of a new point-of-care system for detection of prostate specific antigen

Por Rausch, Steffen, Hennenlotter, Joerg, Wiesenreiter, Josef, Hohneder, Andrea, Heinkele, Julian, Schwentner, Christian, Stenzl, Arnulf, Todenhöfer, Tilman
Publicado no BMC Urol (2016)

Point-of-Care Tests for Bladder Cancer: The Influencing Role of Hematuria

Por Hennenlotter, Joerg, Huber, Severine, Todenhöfer, Tilman, Kuehs, Ursula, Schilling, David, Aufderklamm, Stefan, Gakis, Georgios, Schwentner, Christian, Stenzl, Arnulf
Publicado em 2011

Severe paraneoplastic hypereosinophilia in metastatic renal cell carcinoma

Por Todenhöfer, Tilman, Wirths, Stefan, von Weyhern, Claus Hann, Heckl, Stefan, Horger, Marius, Hennenlotter, Joerg, Stenzl, Arnulf, Kanz, Lothar, Schwentner, Christian
Publicado em 2012

Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma

Por von Klot, Christoph-A, Kramer, Mario W, Peters, Inga, Hennenlotter, Joerg, Abbas, Mahmoud, Scherer, Ralph, Herrmann, Thomas RW, Stenzl, Arnulf, Kuczyk, Markus A, Serth, Juergen, Merseburger, Axel S
Publicado em 2014

HYAL-1 Hyaluronidase: A Potential Prognostic Indicator for Progression to Muscle Invasion and Recurrence in Bladder Cancer

Por Kramer, Mario W., Golshani, Roozbeh, Merseburger, Axel S., Knapp, Judith, Garcia, Alfredo, Hennenlotter, Joerg, Duncan, Robert C., Soloway, Mark S., Jorda, Merce, Kuczyk, Marcus A., Stenzl, Arnulf, Lokeshwar, Vinata B
Publicado em 2009

Immunocytology Is Strong Predictor of Bladder Cancer Presence in Patients With Painless Hematuria: A Multicentre Study

Por Cha, Eugene K., Tirsar, Lenuta-Ancuta, Schwentner, Christian, Christos, Paul J., Mian, Christine, Hennenlotter, Joerg, Martini, Thomas, Stenzl, Arnulf, Pycha, Armin, Shariat, Shahrokh F., Schmitz-Dräger, Bernd J.
Publicado em 2011

GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma

Por PETERS, INGA, GEBAUER, KAI, DUBROWINSKAJA, NATALIA, ATSCHEKZEI, FARANAZ, KRAMER, MARIO W., HENNENLOTTER, JOERG, TEZVAL, HOSSEIN, ABBAS, MAHMOUD, SCHERER, RALPH, MERSEBURGER, AXEL S., STENZL, ARNULF, KUCZYK, MARKUS A., SERTH, JUERGEN
Publicado em 2014

Accurate Risk Assessment of Patients with Asymptomatic Hematuria for the Presence of Bladder Cancer

Por Cha, Eugene K., Tirsar, Lenuta-Ancuta, Schwentner, Christian, Hennenlotter, Joerg, Christos, Paul J., Stenzl, Arnulf, Mian, Christine, Martini, Thomas, Pycha, Armin, Shariat, Shahrokh F., Schmitz-Dräger, Bernd J.
Publicado em 2012